Keratin.
May support hair and nail health. Provides the specific amino acids your body uses to build hair and nails. The idea is to give your body more raw materials to work with.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- Hair HealthNail Health
What Keratin is, and what it does.
- Does it work
- Suits people already covering protein, zinc and biotin who want a cysteine-rich source aimed at nails and hair. Origin matters if you react to wool or poultry material.
- How much to take
- 500 mg daily is the standard dose. Some studies use more, but the data isn't strong enough to justify going higher.
- Time to feel it
- Nails and hair only show change as they grow out, so give it two to three months. That's roughly how long a fingernail takes to grow from base to tip.
- The first dose
- Absolutely nothing. Your body just digests it like any other protein.
- With regular use
- After 2-3 months, you might see stronger, less brittle nails or slightly less hair shedding. Or you might see no change. It's a coin toss.
- How well tolerated
- Well tolerated. It's a protein. Your body knows how to handle it. The only real concern is a potential allergy, especially if it's derived from sheep's wool.
- How it feels
- You don't feel it. Any results are slow and visual. You'll see it in your nails or hairbrush over months, not feel it in your body.
- The overlooked benefit
- The distinctive part isn't the protein, it's the cysteine. Hard keratin is unusually rich in it, and that sulfur amino acid is shared with glutathione synthesis.
500mg a day is where Keratin works.
Source: Beer et al., J Clin Aesthet Dermatol 2014 (Cynatine HNS study)
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
The evidence supporting keratin supplementation is mixed, with some studies showing benefits while others report no significant effects. More research is needed to confirm its efficacy.
- Nail strength and splittingRandomised trial
- Hair strength and sheddingRandomised trial
- Skin hydration and elasticityRandomised trial
- Sulfur amino acid supply as the distinctive input to keratin synthesisNarrative review
- Digestion to peptides and free amino acids rather than intact absorptionNarrative review
Questions people ask about Keratin.
- Will this make my hair grow faster?
- No. It's about strength and quality, not speed. Don't expect faster growth.
- Is this the same as biotin?
- Different. Biotin is a B-vitamin involved in production. Keratin is the actual protein structure itself. They're often taken together.
- Can't I just eat more protein?
- Yes, and you should. A good diet is more important. Keratin supplements just provide a very specific type of protein. It's a targeted approach, but not necessarily better.
- How long until I see results?
- If it works for you, 2-3 months minimum. Hair and nails grow slowly. Patience is required.
- Is it vegan?
- Usually not. Most keratin is sourced from sheep's wool. Check the label for plant-based or 'vegan keratin' alternatives if that's a concern.
- Any side effects?
- Extremely rare. It's just protein. Some people might get an upset stomach, but that's about it.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Hard keratin in hair and nails gets its rigidity from cystine bridges, so cysteine is the amino acid the fibre is built from. Supplying sulfur amino acid substrate feeds the same pathway keratin synthesis draws on.
Biotin is the cofactor for the carboxylases running fatty acid and amino acid metabolism in fast-dividing keratinocytes, the cells that lay down keratin. It supports the manufacturing step rather than supplying the building block.
The follicle matrix is one of the fastest proliferating tissues in the body and relies on zinc-dependent polymerases and transcription factors to keep keratin protein synthesis running. Low zinc status shows up early in hair and nail structure for that reason.
MSM contributes bioavailable sulfur that can enter the cysteine and methionine pool used for keratin disulfide bonding. The route from MSM sulfur into keratin itself is much less directly measured than cysteine, so regard it as a supporting pairing.
Orthosilicic acid participates in cross-linking of glycosaminoglycans and collagen in the tissue that anchors hair and nail. Keratin supplies the fibrous protein while silicon supports the surrounding matrix that holds it.
Silicon contributes to the connective matrix that surrounds keratinising cells. It supports structure around the fibre rather than the fibre protein itself.
Copper is the cofactor for lysyl oxidase, which cross-links the connective scaffold, and for tyrosinase, which builds hair pigment. Because zinc and copper compete for the same intestinal metallothionein handling, keratin formulas that carry generous zinc should carry copper too.
Hard keratin owes its rigidity to dense cystine disulfide bridges, so the cysteine supply sets how tightly the fibre can be cross-linked. NAC delivers cysteine in a stable form and also feeds glutathione synthesis in the follicle.
Collagen builds the dermal and nail bed matrix while keratin builds the fibre that grows out of it. Each covers a different structural compartment.
Hair matrix keratinocytes are among the fastest dividing cells in the body and depend on iron-requiring ribonucleotide reductase for DNA synthesis. Keratin building blocks are only used at full rate when iron status supports that turnover.
Pantothenic acid becomes coenzyme A, which drives the fatty acid synthesis that produces the lipids coating each keratin fibre.
The vitamin D receptor is expressed in keratinocytes and the hair follicle and helps drive the differentiation programme that lays down keratin. Vitamin D governs the schedule while keratin supplies the material.
Keratin and the collagen around it are rich in glycine and serine, so glycine is a bulk substrate for both when fibrous protein synthesis is high.
Ascorbate holds the cysteine and glutathione pool in its reduced form and is the cofactor for the hydroxylases that stabilise collagen in the nail bed and dermis. Both roles sit upstream of visible fibre quality.
Glutathione peroxidases and thioredoxin reductase are selenoproteins that manage the oxidative environment in which follicle keratin is assembled. Selenium supports the redox setting for disulfide formation rather than supplying the protein.
Cysteine is made from methionine through homocysteine and cystathionine, so methionine adequacy sets the ceiling on how much cysteine the body can generate. Keratin is unusually cysteine-rich, which makes that supply route directly relevant to keratin synthesis. This is textbook amino acid metabolism and needs no trial to state.
Both enzymes that convert homocysteine to cysteine require pyridoxal 5-phosphate as cofactor. Without adequate B6 the transsulfuration route to cysteine is constrained no matter how much methionine is available. That makes B6 an upstream determinant of the cysteine pool keratin draws on.
Pyridoxal 5-phosphate is the active cofactor form used by cystathionine beta-synthase and cystathionine gamma-lyase. Supplying it directly skips the hepatic phosphorylation step that pyridoxine requires. The biochemical relationship to cysteine supply is identical.
Sulfite oxidase carries a molybdenum cofactor and catalyses the final step of sulfur amino acid catabolism, converting sulfite to sulfate. A diet or supplement regimen high in cysteine and methionine raises flux through that step. Molybdenum adequacy is what keeps the enzyme functional at higher sulfur amino acid throughput.
S-adenosylmethionine is the methyl donor formed from methionine, and its use generates homocysteine, the branch point that feeds cysteine synthesis. Supplying SAM-e changes flux through that cycle rather than adding sulfur amino acid directly. Read it as a one-carbon relationship, not a keratin building block.
Betaine remethylates homocysteine back to methionine, which is the alternative to sending it down the transsulfuration route toward cysteine. Pushing remethylation therefore competes with cysteine generation for the same homocysteine pool. Which branch dominates depends on methionine status, and the direction is worth stating rather than assuming.
Choline is oxidised to betaine, which then acts in the remethylation branch of homocysteine handling. That places choline upstream of the same branch point that governs cysteine availability. The relationship is metabolic partitioning rather than direct contribution to keratin.
Beyond cysteine, hair keratin carries substantial arginine, serine and glutamate in its head and tail domains. Arginine also has its own role in blood flow through nitric oxide synthesis. The composition point is settled protein chemistry; the delivery point is not measured here.
Serine is one of the most abundant residues in keratin and is also the carbon skeleton that condenses with homocysteine to form cystathionine on the way to cysteine. It therefore sits in the pathway twice, as a building block and as a substrate. That dual position is settled biochemistry.
Proline appears throughout the non-helical domains of keratin and is a defining residue of collagen, which is why the two proteins are often supplemented together. Supplying an abundant residue does not make it rate-limiting. The row records composition, not a demonstrated effect.
Lysine is an indispensable amino acid and is often the limiting one in cereal-heavy diets, so total protein synthesis can be constrained by it. Keratin production draws on the same amino acid pool as every other protein. The relationship is general protein nutrition applied to a specific protein.
Riboflavin-derived FAD is the cofactor for MTHFR, which supplies the methyl group for homocysteine remethylation, and for glutathione reductase, which recycles the main cysteine-containing antioxidant. Both sit alongside the sulfur amino acid economy that keratin depends on. This is cofactor biochemistry rather than a keratin-specific finding.
Pantothenic acid is the backbone of coenzyme A, which carries a free thiol and is central to acyl transfer throughout metabolism, including the lipid synthesis that accompanies hair shaft formation. The vitamin is a long-standing component of hair and nail formulas for that reason. The cofactor role is established; effects on hair are not measured here.
Manganese is the metal centre of MnSOD and a cofactor for enzymes involved in connective tissue turnover. High supplemental iron competes with manganese for the same transport route, which is worth noting where a hair formula carries both. This is trace element handling rather than an effect on the protein itself.
ATP is functionally Mg-ATP, and ribosomal peptide bond formation, aminoacyl-tRNA charging and amino acid transport all consume it. Keratin is a protein and is built by the same machinery as any other. This is universal biochemistry, not a keratin-specific claim.
Retinoic acid acting at nuclear retinoid receptors is one of the principal regulators of which keratin genes a keratinocyte expresses as it differentiates. That is transcriptional control of keratin identity, not of keratin quantity in a supplement sense. Vitamin A is fat-soluble and accumulates, so intake sits within established upper intake guidance.
Vitamin A metabolites govern the switch between basal and differentiated keratin gene expression in stratified epithelium. The relationship is regulatory, describing which keratins a cell makes. Fat-soluble accumulation makes the intake ceiling the practical consideration in a formula.
Whey carries alpha-lactalbumin and beta-lactoglobulin, both unusually rich in cystine, which makes it a dense dietary source of sulfur amino acid. Hard keratin carries cysteine at an unusually high proportion relative to most structural proteins. Supplying that residue through whole protein is the same nutritional route as supplying it as a free amino acid, at a different absorption profile.
Cysteine is drawn down by three competing routes: protein synthesis, glutathione production and oxidation to taurine and sulfate. Taurine sits at the end of one of those branches rather than feeding back into the others. Naming it as competing for the cysteine pool is more accurate than calling it supportive.
Native keratin resists ordinary digestive proteases precisely because its disulfide crosslinks hold the structure closed, which is why supplement keratin is hydrolysed during manufacture rather than fed intact. Added proteases act on already-hydrolysed peptide material rather than on intact keratin. The distinction matters because the manufacturing step, not the capsule, is what makes keratin digestible.
Pepsin initiates protein breakdown in the acidic stomach, and its activity depends on low gastric pH. Hydrolysed keratin arrives already cleaved into short peptides, so pepsin has less work to do on it than on an intact protein. The relationship describes digestion of the ingredient rather than an effect on hair or nail.
Betaine hydrochloride lowers gastric pH, and pepsin needs an acidic environment to cleave protein efficiently. For any protein ingredient this is an upstream digestive consideration. It is a general protein digestion point and not specific to keratin.
The cornified envelope that keratinocytes build is sealed by a lipid matrix of ceramides, cholesterol and free fatty acids, so the barrier is protein and lipid together rather than protein alone. Long-chain omega-3s feed the lipid side of that structure. The pairing addresses two different components of the same tissue.
Ceramides are the dominant lipid class in the extracellular matrix between corneocytes, and the corneocyte itself is a keratin-filled cell shell. Barrier function depends on both parts. Combining a keratin ingredient with a ceramide ingredient targets the protein and the lipid compartments separately.
Hyaluronan holds water in the dermal matrix, a different compartment from the keratinised epidermal layer above it. The two are combined in skin and hair formulas because they address structure and hydration separately. That is formulation logic rather than a shared pathway.
Glutamine is the most abundant free amino acid in plasma and a nitrogen donor for numerous synthetic reactions, and it also feeds rapidly dividing cells such as those in the hair follicle matrix. Follicle keratinocytes are among the fastest dividing cells in the body. The relationship is general substrate supply, not a keratin-specific mechanism.
Thyroid hormones influence the duration of the growth phase in the hair follicle and modulate keratin gene expression in the follicle epithelium, and iodine is the element those hormones are built from. This is an upstream endocrine relationship rather than a nutrient contribution to the protein. Iodine intake has a defined upper level, which is the practical consideration in a formula.
Talk to a doctor before taking Keratin if any of these apply to you: Pregnancy, Breastfeeding, Allergies. These are flags to check first, not effects Keratin is known to cause.
Not medical advice. Show the label to your pharmacist.What Keratin actually does.
Keratins are intermediate filament proteins that assemble as obligate pairs of one type I and one type II chain, forming the coiled-coil filaments that give hair, nail and the outer skin layer their mechanical strength.
Hard keratin of hair and nail is heavily crosslinked by disulfide bonds between cysteine residues, and that crosslink density is what makes the tissue rigid and chemically resistant.
Cysteine is the residue present at unusually high proportion in hard keratin, which makes sulfur amino acid supply the nutritionally distinctive input to keratin synthesis rather than total protein alone.
Ingested keratin is digested to peptides and free amino acids like any other dietary protein; it is not absorbed intact and does not travel to hair or nail as keratin.
Where Keratin comes from.
Sheep wool, or sometimes poultry feathers, is cleaned and then treated with chemicals or enzymes that break the strong sulfur bonds holding the protein together. That turns it into short soluble pieces, which are filtered and dried into a powder the body can digest.
Made from an animal material. Species and tissue are the things worth knowing, and both belong on a label.
Most supplement keratin starts as scoured sheep wool, a by-product of the wool trade; feather-derived material uses poultry processing by-product instead
Raw wool is washed free of lanolin, suint and dirt, since the grease fraction interferes with every downstream chemical step
The disulfide crosslinks holding the protein closed are broken, either reductively with a thiol reagent such as a sulfite or thioglycolate, or oxidatively with peracid; this is the step that makes keratin soluble at all
The reduced protein is dissolved out of the fibre under alkaline or urea-containing conditions and separated from the undissolved cuticle residue
The solubilised protein is cut into peptides by acid, alkali or protease; enzymatic hydrolysis runs at milder pH and temperature and preserves more of the sulfur amino acid content than harsh chemical hydrolysis
The hydrolysate is neutralised, filtered and often desalted or ultrafiltered to a defined molecular weight range, removing residual reagent and salt
Dried to a powder for capsules and tablets, or held as a liquid concentrate for cosmetic and topical formulation
The forms it comes in.
The essence, in one line each.
- Adult women taking 500 mg or 1000 mg a day of a feather-derived keratin hydrolysate for 90 days showed improvements in skin roughness, wrinkle measures, deep moisturisation, elasticity and nail hardness compared with placebo, while fibre anisotropy and density improved from baseline but only trended against placebo.Randomised trial. Tursi et al., 2024 (Journal of Cosmetic Dermatology). PMID 39367631 ↗
- In 50 women, 90 days of a supplement providing 500 mg of solubilised keratin plus vitamins and minerals improved measures of hair loss, hair growth, hair strength and nail strength compared with placebo, so the keratin was not tested on its own.Randomised trial. Beer et al., 2014 (The Scientific World Journal). PMID 25386609 ↗
- In physically active adults, chronic soluble keratin supplementation did not produce a detectable change in body composition or blood markers compared with placebo.Randomised trial. Crum et al., 2018 (Journal of the International Society of Sports Nutrition). PMID 30261892 ↗
- Narrative review describing how inherited variants in basal keratin genes alter the mechanical resilience of the epidermis, and the difficulties of running clinical trials in that setting; it grounds keratin's structural role rather than any supplement effect.Narrative review. Wally et al., 2025 (Orphanet Journal of Rare Diseases). PMID 40542406 ↗
- Keratinase production by a Bacillus cereus strain grown on feather waste was optimised and the resulting enzyme characterised in laboratory assays; relevant to how keratin is broken down during manufacture.In vitro study. Sim et al., 2026 (Preparative Biochemistry and Biotechnology). PMID 41838888 ↗
- Pilot-scale inoculum-free fermentation broke down raw chicken feathers, recovering ammonium and producing keratinase, with the microbial community characterised through the process; non-human and process-focused.In vitro study. de-Santos-Casado et al., 2026 (World Journal of Microbiology and Biotechnology). PMID 42184079 ↗
- Combined microbial and enzymatic fermentation of feather meal produced peptide fractions that were characterised in laboratory assays across several pathways; a compositional and mechanistic result, not a human outcome.In vitro study. Zhang et al., 2026 (Poultry Science). PMID 41980552 ↗
- Mineral element content of keratinised hoof wall differed between two horse breeds; it measures the composition of a keratin tissue, not the effect of any supplement.Animal study. Stanek et al., 2026 (Biological Trace Element Research). PMID 41436706 ↗
- Primary limbal epithelial cells shifted their keratin gene and protein expression when exposed to differentiation-inducing conditions; keratin expression here is a cellular differentiation marker.In vitro study. Suiwal et al., 2026 (Biology). PMID 42041888 ↗
- A twelve-week pilot study of an oral hibiscus-derived collagen alternative reported changes in skin measures; keratin is named in the background rather than being the substance tested, so this is not evidence for keratin.Open-label trial. Baek et al., 2025 (International Journal of Molecular Sciences). PMID 40806423 ↗
These are the studies our verdict leans on, chosen from the 65,627 we read for Keratin. The full linked list is below.
The studies, linked.
8 sources behind our Keratin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialOral Hydrolyzed Keratin Peptide Powder Improves Hair Quality and Scalp Barrier Function: A 24-Week Randomized, Double-Blind, Placebo-Controlled TrialClinicalTrials.gov ↗NA · 120 participants · Completed
- Clinical trialA 3-Month, Randomized, Single-Blind, Placebo-Controlled Study Evaluating the Ability of Nutra Harmony "Biotin, Collagen &Amp;Amp; Keratin Beauty Complex" Dietary Supplement Promotion in Hair Thickness and Hair Strength in Individuals With Self-Perceived Thinning HairClinicalTrials.gov ↗NA · 80 participants · Completed
- Clinical trialA Randomized Clinical Pilot Evaluating The Efficacy For Two Application Regimens Of A Unique Keratin Based Graft In The Treatment Of Non-Healing Diabetic Foot UlcersClinicalTrials.gov ↗NA · 26 participants · Completed
- Clinical trialA Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)ClinicalTrials.gov ↗PHASE1 · 6 participants · Completed
- Clinical trialA Controlled Data Collection and Prospective Treatment Study to Evaluate the Efficacy of ProgenaMatrix™ in the Management of Diabetic Foot UlcersClinicalTrials.gov ↗NA · 100 participants · Active not recruiting
- Clinical trialA Phase II, Closed Label, Placebo Controlled, Randomized, Double-Blinded Clinical Trial to Evaluate the Efficacy and Safety of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex (TAMES)ClinicalTrials.gov ↗PHASE2 · 40 participants · Recruiting
- Clinical trialEfficacy and Safety of Keratin Hair Therapy on the Health of Hair and ScalpClinicalTrials.gov ↗NA · 30 participants · Unknown
- Clinical trialDetermination of the Biological Activity of Enriched Serums on Healthy Volunteers After Consumption of the Kera-Diet® Ingredient, CnC2024 - Kera-Diet®ClinicalTrials.gov ↗NA · 10 participants · Active not recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 18,570 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Keratin is, not how risky it is. A report is not proof Keratin caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.